166 related articles for article (PubMed ID: 24528628)
1. Influenza reverse genetics: dissecting immunity and pathogenesis.
Ye S; Evans JG; Stambas J
Expert Rev Mol Med; 2014 Feb; 16():e2. PubMed ID: 24528628
[TBL] [Abstract][Full Text] [Related]
2. Reverse Genetics Approaches for the Development of Influenza Vaccines.
Nogales A; Martínez-Sobrido L
Int J Mol Sci; 2016 Dec; 18(1):. PubMed ID: 28025504
[TBL] [Abstract][Full Text] [Related]
3. [Using reverse genetics method for developing recombinant strains of influenza viruses acceptable for use as live attenuated vaccines].
Merkulov VA; Lebedev VN; Plekhanova TM; Maksimov VA; Korovkin SA; Mironov AN
Zh Mikrobiol Epidemiol Immunobiol; 2009; (2):111-7. PubMed ID: 19462520
[TBL] [Abstract][Full Text] [Related]
4. Taming influenza viruses.
Ozawa M; Kawaoka Y
Virus Res; 2011 Dec; 162(1-2):8-11. PubMed ID: 21968297
[TBL] [Abstract][Full Text] [Related]
5. Influenza A virus molecular virology techniques.
Zhou B; Wentworth DE
Methods Mol Biol; 2012; 865():175-92. PubMed ID: 22528160
[TBL] [Abstract][Full Text] [Related]
6. Live Attenuated Influenza Vaccine contains Substantial and Unexpected Amounts of Defective Viral Genomic RNA.
Gould PS; Easton AJ; Dimmock NJ
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934167
[TBL] [Abstract][Full Text] [Related]
7. Trends in development of the influenza vaccine with broader cross-protection.
Stropkovská A; Janulíková J; Varecková E
Acta Virol; 2010; 54(1):7-19. PubMed ID: 20201609
[TBL] [Abstract][Full Text] [Related]
8. AGL2017-82570-RReverse genetics approaches for the development of new vaccines against influenza A virus infections.
Martinez-Sobrido L; DeDiego ML; Nogales A
Curr Opin Virol; 2020 Oct; 44():26-34. PubMed ID: 32599532
[TBL] [Abstract][Full Text] [Related]
9. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
[TBL] [Abstract][Full Text] [Related]
10. Reverse genetics approach towards understanding pathogenesis of H5N1 Hong Kong influenza A virus infection.
Hatta M; Neumann G; Kawaoka Y
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1841-3. PubMed ID: 11779382
[TBL] [Abstract][Full Text] [Related]
11. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses.
Li S; Liu C; Klimov A; Subbarao K; Perdue ML; Mo D; Ji Y; Woods L; Hietala S; Bryant M
J Infect Dis; 1999 May; 179(5):1132-8. PubMed ID: 10191214
[TBL] [Abstract][Full Text] [Related]
12. A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.
Stech J; Klenk HD
Berl Munch Tierarztl Wochenschr; 2006; 119(3-4):186-91. PubMed ID: 16573209
[TBL] [Abstract][Full Text] [Related]
13. An improved reverse genetics system for influenza A virus generation and its implications for vaccine production.
Neumann G; Fujii K; Kino Y; Kawaoka Y
Proc Natl Acad Sci U S A; 2005 Nov; 102(46):16825-9. PubMed ID: 16267134
[TBL] [Abstract][Full Text] [Related]
14. Prospects for universal influenza virus vaccine.
Gerhard W; Mozdzanowska K; Zharikova D
Emerg Infect Dis; 2006 Apr; 12(4):569-74. PubMed ID: 16704803
[TBL] [Abstract][Full Text] [Related]
15. Development of vaccine strains of H5 and H7 influenza viruses.
Soda K; Sakoda Y; Isoda N; Kajihara M; Haraguchi Y; Shibuya H; Yoshida H; Sasaki T; Sakamoto R; Saijo K; Hagiwara J; Kida H
Jpn J Vet Res; 2008 Jan; 55(2-3):93-8. PubMed ID: 18318111
[TBL] [Abstract][Full Text] [Related]
16. Making better influenza virus vaccines?
Palese P
Emerg Infect Dis; 2006 Jan; 12(1):61-5. PubMed ID: 16494719
[TBL] [Abstract][Full Text] [Related]
17. [Characteristics of influenza immunity and prospects of achieving virus-specific prevention of influenza].
Shvartsman IaS; Tsybul'skaia NV; Ispolatova AV
Usp Sovrem Biol; 1982; 94(3):446-60. PubMed ID: 6186100
[No Abstract] [Full Text] [Related]
18. Reverse genetics of influenza virus.
Neumann G; Kawaoka Y
Virology; 2001 Sep; 287(2):243-50. PubMed ID: 11531402
[TBL] [Abstract][Full Text] [Related]
19. Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza.
Lee CW; Senne DA; Suarez DL
Vaccine; 2004 Aug; 22(23-24):3175-81. PubMed ID: 15297071
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of live attenuated influenza viruses.
Jin H; Chen Z; Liu J; Kemble G
Methods Mol Biol; 2012; 865():163-74. PubMed ID: 22528159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
